Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on New Analyst Forecast: $EXEL Given 'Buy' Rating - Nasdaq

New Analyst Forecast: $EXEL Given 'Buy' Rating  Nasdaq

New Analyst Forecast: $EXEL Given 'Buy' Rating - Nasdaq

Click here to get full coverage on EXEL: HC Wainwright & Co. Raises Price Target for Exelixis | EXEL Stock News - GuruFocus

EXEL: HC Wainwright & Co. Raises Price Target for Exelixis | EXEL Stock News  GuruFocus

EXEL: HC Wainwright & Co. Raises Price Target for Exelixis | EXEL Stock News - GuruFocus

Click here to get full coverage on 3 Reasons Growth Investors Will Love Exelixis (EXEL) - Yahoo Finance

3 Reasons Growth Investors Will Love Exelixis (EXEL)  Yahoo Finance

3 Reasons Growth Investors Will Love Exelixis (EXEL) - Yahoo Finance

Click here to get full coverage on Stephens Upgrades Exelixis (EXEL) Stock, Raises PT - Insider Monkey

Stephens Upgrades Exelixis (EXEL) Stock, Raises PT  Insider Monkey

Stephens Upgrades Exelixis (EXEL) Stock, Raises PT - Insider Monkey

Click here to get full coverage on Exelixis, Inc. (EXEL) Stock Analysis: Riding the Wave of 30.60% Revenue Growth in the Biotechnology Sphere - DirectorsTalk Interviews

Exelixis, Inc. (EXEL) Stock Analysis: Riding the Wave of 30.60% Revenue Growth in the Biotechnology Sphere  DirectorsTalk Interviews

Exelixis, Inc. (EXEL) Stock Analysis: Riding the Wave of 30.60% Revenue Growth in the Biotechnology Sphere - DirectorsTalk Interviews

Click here to get full coverage on Exelixis (NasdaqGS:EXEL) Reports Positive Phase 3 Trial Results For Colorectal Cancer - simplywall.st

Exelixis (NasdaqGS:EXEL) Reports Positive Phase 3 Trial Results For Colorectal Cancer  simplywall.st

Exelixis (NasdaqGS:EXEL) Reports Positive Phase 3 Trial Results For Colorectal Cancer - simplywall.st

Click here to get full coverage on Zacks.com featured highlights include Exelixis, Lyft and Kinross Gold - TradingView

Zacks.com featured highlights include Exelixis, Lyft and Kinross Gold  TradingView

Zacks.com featured highlights include Exelixis, Lyft and Kinross Gold - TradingView

Click here to get full coverage on Exelixis (NASDAQ:EXEL) Jumps 5.8% This Week, Though Earnings Growth Is Still Tracking Behind Three-year Shareholder Returns - 富途牛牛

Exelixis (NASDAQ:EXEL) Jumps 5.8% This Week, Though Earnings Growth Is Still Tracking Behind Three-year Shareholder Returns  富途牛牛

Exelixis (NASDAQ:EXEL) Jumps 5.8% This Week, Though Earnings Growth Is Still Tracking Behind Three-year Shareholder Returns - 富途牛牛

Click here to get full coverage on Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains? - Yahoo Finance

Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains?  Yahoo Finance

Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains? - Yahoo Finance

Click here to get full coverage on Why Is Exelixis (EXEL) Down 7.2% Since Last Earnings Report? - Nasdaq

Why Is Exelixis (EXEL) Down 7.2% Since Last Earnings Report?  Nasdaq

Why Is Exelixis (EXEL) Down 7.2% Since Last Earnings Report? - Nasdaq

Click here to get full coverage on Exelixis, Inc.'s (NASDAQ:EXEL) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st

Exelixis, Inc.'s (NASDAQ:EXEL) Stock's On An Uptrend: Are Strong Financials Guiding The Market?  simplywall.st

Exelixis, Inc.'s (NASDAQ:EXEL) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st

Click here to get full coverage on BofA Hikes Exelixis, Inc. (EXEL) Target Amid CRC Caution - Yahoo Finance

BofA Hikes Exelixis, Inc. (EXEL) Target Amid CRC Caution  Yahoo Finance

BofA Hikes Exelixis, Inc. (EXEL) Target Amid CRC Caution - Yahoo Finance

Click here to get full coverage on EXEL or ARGX: Which Is the Better Value Stock Right Now? - Nasdaq

EXEL or ARGX: Which Is the Better Value Stock Right Now?  Nasdaq

EXEL or ARGX: Which Is the Better Value Stock Right Now? - Nasdaq

Click here to get full coverage on EXEL Stock Rises on Positive Data From Colorectal Cancer Study - Yahoo Finance

EXEL Stock Rises on Positive Data From Colorectal Cancer Study  Yahoo Finance

EXEL Stock Rises on Positive Data From Colorectal Cancer Study - Yahoo Finance

Click here to get full coverage on Here's Why Exelixis (EXEL) is a Strong Momentum Stock - Yahoo Finance

Here's Why Exelixis (EXEL) is a Strong Momentum Stock  Yahoo Finance

Here's Why Exelixis (EXEL) is a Strong Momentum Stock - Yahoo Finance

Click here to get full coverage on 3 Underfollowed Stocks on the Move Now (OLO, PLMR, EXEL) - Yahoo Finance

3 Underfollowed Stocks on the Move Now (OLO, PLMR, EXEL)  Yahoo Finance

3 Underfollowed Stocks on the Move Now (OLO, PLMR, EXEL) - Yahoo Finance

Click here to get full coverage on Exelixis, Inc. (EXEL) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

Exelixis, Inc. (EXEL) Soars to 52-Week High, Time to Cash Out?  Yahoo Finance

Exelixis, Inc. (EXEL) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

Click here to get full coverage on Exelixis: Zanzalintinib MOA Overcomes Competing CRC Regorafenib Treatment (NASDAQ:EXEL) - Seeking Alpha

Exelixis: Zanzalintinib MOA Overcomes Competing CRC Regorafenib Treatment (NASDAQ:EXEL)  Seeking Alpha

Exelixis: Zanzalintinib MOA Overcomes Competing CRC Regorafenib Treatment (NASDAQ:EXEL) - Seeking Alpha

Click here to get full coverage on Exelixis (EXEL) is a Great Momentum Stock: Should You Buy? - Nasdaq

Exelixis (EXEL) is a Great Momentum Stock: Should You Buy?  Nasdaq

Exelixis (EXEL) is a Great Momentum Stock: Should You Buy? - Nasdaq

Click here to get full coverage on EXEL Industries: Total number of voting rights and shares at 05.31.2025 - GlobeNewswire

EXEL Industries: Total number of voting rights and shares at 05.31.2025  GlobeNewswire

EXEL Industries: Total number of voting rights and shares at 05.31.2025 - GlobeNewswire

Click here to get full coverage on Exel Composites supports resilience of biomimetic hydrokinetic system by EEL Energy - CompositesWorld

Exel Composites supports resilience of biomimetic hydrokinetic system by EEL Energy  CompositesWorld

Exel Composites supports resilience of biomimetic hydrokinetic system by EEL Energy - CompositesWorld

Click here to get full coverage on Here's Why Exelixis (EXEL) is a Strong Value Stock - Yahoo Finance

Here's Why Exelixis (EXEL) is a Strong Value Stock  Yahoo Finance

Here's Why Exelixis (EXEL) is a Strong Value Stock - Yahoo Finance

Click here to get full coverage on Is Exelixis, Inc. (EXEL) One of the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies? - Yahoo Finance

Is Exelixis, Inc. (EXEL) One of the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?  Yahoo Finance

Is Exelixis, Inc. (EXEL) One of the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies? - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $EXEL Given 'Underperform' Rating - Nasdaq

New Analyst Forecast: $EXEL Given 'Underperform' Rating  Nasdaq

New Analyst Forecast: $EXEL Given 'Underperform' Rating - Nasdaq

Click here to get full coverage on Is Exelixis, Inc. (EXEL) The Most Profitable Biotech Stock To Buy Right Now? - Yahoo Finance

Is Exelixis, Inc. (EXEL) The Most Profitable Biotech Stock To Buy Right Now?  Yahoo Finance

Is Exelixis, Inc. (EXEL) The Most Profitable Biotech Stock To Buy Right Now? - Yahoo Finance

Click here to get full coverage on 4 stocks to watch on Monday: NVO, EXEL, BABA and FI (FI:NYSE) - Seeking Alpha

4 stocks to watch on Monday: NVO, EXEL, BABA and FI (FI:NYSE)  Seeking Alpha

4 stocks to watch on Monday: NVO, EXEL, BABA and FI (FI:NYSE) - Seeking Alpha

Click here to get full coverage on Here's Why Exelixis (EXEL) is a Strong Growth Stock - Yahoo Finance

Here's Why Exelixis (EXEL) is a Strong Growth Stock  Yahoo Finance

Here's Why Exelixis (EXEL) is a Strong Growth Stock - Yahoo Finance

Click here to get full coverage on Exelixis, Inc. (EXEL): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy - Yahoo Finance

Exelixis, Inc. (EXEL): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy  Yahoo Finance

Exelixis, Inc. (EXEL): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy - Yahoo Finance

Click here to get full coverage on Why Exelixis (EXEL) is a Top Value Stock for the Long-Term - Yahoo Finance

Why Exelixis (EXEL) is a Top Value Stock for the Long-Term  Yahoo Finance

Why Exelixis (EXEL) is a Top Value Stock for the Long-Term - Yahoo Finance

Click here to get full coverage on Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term - Nasdaq

Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term  Nasdaq

Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term - Nasdaq

Click here to get full coverage on EXEL Industries: 2024–2025 half-year results - GlobeNewswire

EXEL Industries: 2024–2025 half-year results  GlobeNewswire

EXEL Industries: 2024–2025 half-year results - GlobeNewswire

Click here to get full coverage on Unlocking Exelixis (EXEL) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance

Unlocking Exelixis (EXEL) International Revenues: Trends, Surprises, and Prospects  Yahoo Finance

Unlocking Exelixis (EXEL) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance

Click here to get full coverage on Here's Why Exelixis (EXEL) is a Strong Value Stock - Nasdaq

Here's Why Exelixis (EXEL) is a Strong Value Stock  Nasdaq

Here's Why Exelixis (EXEL) is a Strong Value Stock - Nasdaq

Click here to get full coverage on Exelixis (EXEL) Gets a Hold from UBS - The Globe and Mail

Exelixis (EXEL) Gets a Hold from UBS  The Globe and Mail

Exelixis (EXEL) Gets a Hold from UBS - The Globe and Mail

Click here to get full coverage on 3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL) - Yahoo Finance

3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL)  Yahoo Finance

3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL) - Yahoo Finance

Click here to get full coverage on "It has something to do with them dam lows" - Nick Van Exel thinks players today are prone to Achilles injuries because they don't wear high tops anymore - Yahoo Sports

"It has something to do with them dam lows" - Nick Van Exel thinks players today are prone to Achilles injuries because they don't wear high tops anymore  Yahoo Sports

"It has something to do with them dam lows" - Nick Van Exel thinks players today are prone to Achilles injuries because they don't wear high tops anymore - Yahoo Sports

Click here to get full coverage on Exel, Flying Whales advance airship R&D collaboration - CompositesWorld

Exel, Flying Whales advance airship R&D collaboration  CompositesWorld

Exel, Flying Whales advance airship R&D collaboration - CompositesWorld

Click here to get full coverage on Insider Sale: EVP of $EXEL Sells 52,636 Shares - Nasdaq

Insider Sale: EVP of $EXEL Sells 52,636 Shares  Nasdaq

Insider Sale: EVP of $EXEL Sells 52,636 Shares - Nasdaq

Click here to get full coverage on Ahead of Exelixis (EXEL) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Nasdaq

Ahead of Exelixis (EXEL) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics  Nasdaq

Ahead of Exelixis (EXEL) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Nasdaq

Click here to get full coverage on First Week of EXEL February 2026 Options Trading - Nasdaq

First Week of EXEL February 2026 Options Trading  Nasdaq

First Week of EXEL February 2026 Options Trading - Nasdaq

Click here to get full coverage on Insider Sale: Director at $EXEL Sells 19,294 Shares - Nasdaq

Insider Sale: Director at $EXEL Sells 19,294 Shares  Nasdaq

Insider Sale: Director at $EXEL Sells 19,294 Shares - Nasdaq

Click here to get full coverage on Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?  Yahoo Finance

Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Click here to get full coverage on Exelixis (NasdaqGS:EXEL) Reports Robust Q1 2025 Earnings and Revenue Growth - simplywall.st

Exelixis (NasdaqGS:EXEL) Reports Robust Q1 2025 Earnings and Revenue Growth  simplywall.st

Exelixis (NasdaqGS:EXEL) Reports Robust Q1 2025 Earnings and Revenue Growth - simplywall.st

Click here to get full coverage on EXEL Industries: Total number of voting rights and shares at 05.31.2025 - Yahoo Finance

EXEL Industries: Total number of voting rights and shares at 05.31.2025  Yahoo Finance

EXEL Industries: Total number of voting rights and shares at 05.31.2025 - Yahoo Finance

Click here to get full coverage on EXEL Industries: Second quarter 2024–2025 sales down 3.8% - GlobeNewswire

EXEL Industries: Second quarter 2024–2025 sales down 3.8%  GlobeNewswire

EXEL Industries: Second quarter 2024–2025 sales down 3.8% - GlobeNewswire

Click here to get full coverage on Exelixis, Inc. (EXEL): Among Renaissance Technologies Portfolio’s Top Stock Picks - Yahoo Finance

Exelixis, Inc. (EXEL): Among Renaissance Technologies Portfolio’s Top Stock Picks  Yahoo Finance

Exelixis, Inc. (EXEL): Among Renaissance Technologies Portfolio’s Top Stock Picks - Yahoo Finance

Click here to get full coverage on Exelixis (EXEL) Sees Upgraded Rating and Increased Price Target | EXEL Stock News - GuruFocus

Exelixis (EXEL) Sees Upgraded Rating and Increased Price Target | EXEL Stock News  GuruFocus

Exelixis (EXEL) Sees Upgraded Rating and Increased Price Target | EXEL Stock News - GuruFocus

Click here to get full coverage on EXEL Industries: 2023–2024 full-year results - GlobeNewswire

EXEL Industries: 2023–2024 full-year results  GlobeNewswire

EXEL Industries: 2023–2024 full-year results - GlobeNewswire

Click here to get full coverage on Stephens Boosts Exelixis (EXEL) with Upgraded Rating and Positiv - GuruFocus

Stephens Boosts Exelixis (EXEL) with Upgraded Rating and Positiv  GuruFocus

Stephens Boosts Exelixis (EXEL) with Upgraded Rating and Positiv - GuruFocus

Click here to get full coverage on JA Solar to supply 260MW of TOPCon modules to Exel Solar - PV Tech

JA Solar to supply 260MW of TOPCon modules to Exel Solar  PV Tech

JA Solar to supply 260MW of TOPCon modules to Exel Solar - PV Tech

Click here to get full coverage on Jefferies Ups Price Target on Exelixis (EXEL) Amid Positive Tria - GuruFocus

Jefferies Ups Price Target on Exelixis (EXEL) Amid Positive Tria  GuruFocus

Jefferies Ups Price Target on Exelixis (EXEL) Amid Positive Tria - GuruFocus

Click here to get full coverage on Exelixis (EXEL) Gains Momentum with Increased Price Target and P - GuruFocus

Exelixis (EXEL) Gains Momentum with Increased Price Target and P  GuruFocus

Exelixis (EXEL) Gains Momentum with Increased Price Target and P - GuruFocus

Click here to get full coverage on EXEL: Analyst Raises Price Target for Exelixis to $50 | EXEL Stock News - GuruFocus

EXEL: Analyst Raises Price Target for Exelixis to $50 | EXEL Stock News  GuruFocus

EXEL: Analyst Raises Price Target for Exelixis to $50 | EXEL Stock News - GuruFocus

Click here to get full coverage on Exelixis (EXEL) Achieves Phase 3 Trial Success for Key Drug Zanzalintinib | EXEL Stock News - GuruFocus

Exelixis (EXEL) Achieves Phase 3 Trial Success for Key Drug Zanzalintinib | EXEL Stock News  GuruFocus

Exelixis (EXEL) Achieves Phase 3 Trial Success for Key Drug Zanzalintinib | EXEL Stock News - GuruFocus

Click here to get full coverage on Exelixis Inc (EXEL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Exelixis Inc (EXEL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...  Yahoo Finance

Exelixis Inc (EXEL)

Price Chart

Key Statistics

Technicals

About EXEL

Latest News

New Analyst Forecast: $EXEL Given 'Buy' Rating - Nasdaq

EXEL: HC Wainwright & Co. Raises Price Target for Exelixis | EXEL Stock News - GuruFocus

3 Reasons Growth Investors Will Love Exelixis (EXEL) - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers